nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.199	0.363	CbGbCtD
Glimepiride—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.199	0.363	CbGbCtD
Glimepiride—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.151	0.275	CbGbCtD
Glimepiride—Gliclazide—VEGFA—chronic obstructive pulmonary disease	0.00668	0.709	CrCbGaD
Glimepiride—Gliclazide—ALB—chronic obstructive pulmonary disease	0.0018	0.191	CrCbGaD
Glimepiride—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00331	CcSEcCtD
Glimepiride—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00327	CcSEcCtD
Glimepiride—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00327	CcSEcCtD
Glimepiride—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00325	CcSEcCtD
Glimepiride—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00325	CcSEcCtD
Glimepiride—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00324	CcSEcCtD
Glimepiride—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00323	CcSEcCtD
Glimepiride—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00321	CcSEcCtD
Glimepiride—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.00321	CcSEcCtD
Glimepiride—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00319	CcSEcCtD
Glimepiride—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00317	CcSEcCtD
Glimepiride—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00316	CcSEcCtD
Glimepiride—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00316	CcSEcCtD
Glimepiride—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00315	CcSEcCtD
Glimepiride—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00312	CcSEcCtD
Glimepiride—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00311	CcSEcCtD
Glimepiride—Tension—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00311	CcSEcCtD
Glimepiride—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.0031	CcSEcCtD
Glimepiride—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00307	CcSEcCtD
Glimepiride—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00307	CcSEcCtD
Glimepiride—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00307	CcSEcCtD
Glimepiride—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00307	CcSEcCtD
Glimepiride—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00303	CcSEcCtD
Glimepiride—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00302	CcSEcCtD
Glimepiride—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00299	CcSEcCtD
Glimepiride—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00299	CcSEcCtD
Glimepiride—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00298	CcSEcCtD
Glimepiride—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00297	CcSEcCtD
Glimepiride—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00297	CcSEcCtD
Glimepiride—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00128	0.00295	CcSEcCtD
Glimepiride—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00293	CcSEcCtD
Glimepiride—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00292	CcSEcCtD
Glimepiride—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00291	CcSEcCtD
Glimepiride—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00291	CcSEcCtD
Glimepiride—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00126	0.0029	CcSEcCtD
Glimepiride—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.0029	CcSEcCtD
Glimepiride—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00289	CcSEcCtD
Glimepiride—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00289	CcSEcCtD
Glimepiride—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00289	CcSEcCtD
Glimepiride—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00287	CcSEcCtD
Glimepiride—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00285	CcSEcCtD
Glimepiride—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00283	CcSEcCtD
Glimepiride—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00282	CcSEcCtD
Glimepiride—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.0028	CcSEcCtD
Glimepiride—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0028	CcSEcCtD
Glimepiride—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0028	CcSEcCtD
Glimepiride—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00278	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00276	CcSEcCtD
Glimepiride—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00275	CcSEcCtD
Glimepiride—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00274	CcSEcCtD
Glimepiride—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00273	CcSEcCtD
Glimepiride—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00273	CcSEcCtD
Glimepiride—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00273	CcSEcCtD
Glimepiride—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.0027	CcSEcCtD
Glimepiride—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00269	CcSEcCtD
Glimepiride—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00268	CcSEcCtD
Glimepiride—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00268	CcSEcCtD
Glimepiride—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00268	CcSEcCtD
Glimepiride—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00264	CcSEcCtD
Glimepiride—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00264	CcSEcCtD
Glimepiride—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00264	CcSEcCtD
Glimepiride—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00263	CcSEcCtD
Glimepiride—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00263	CcSEcCtD
Glimepiride—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00262	CcSEcCtD
Glimepiride—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00258	CcSEcCtD
Glimepiride—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00258	CcSEcCtD
Glimepiride—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00258	CcSEcCtD
Glimepiride—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00254	CcSEcCtD
Glimepiride—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00254	CcSEcCtD
Glimepiride—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00253	CcSEcCtD
Glimepiride—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00253	CcSEcCtD
Glimepiride—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00252	CcSEcCtD
Glimepiride—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00252	CcSEcCtD
Glimepiride—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.0025	CcSEcCtD
Glimepiride—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00249	CcSEcCtD
Glimepiride—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00248	CcSEcCtD
Glimepiride—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00248	CcSEcCtD
Glimepiride—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00244	CcSEcCtD
Glimepiride—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00241	CcSEcCtD
Glimepiride—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00241	CcSEcCtD
Glimepiride—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.0024	CcSEcCtD
Glimepiride—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.0024	CcSEcCtD
Glimepiride—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.0024	CcSEcCtD
Glimepiride—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00238	CcSEcCtD
Glimepiride—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00238	CcSEcCtD
Glimepiride—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00236	CcSEcCtD
Glimepiride—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00236	CcSEcCtD
Glimepiride—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00234	CcSEcCtD
Glimepiride—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00234	CcSEcCtD
Glimepiride—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00232	CcSEcCtD
Glimepiride—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00232	CcSEcCtD
Glimepiride—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000997	0.0023	CcSEcCtD
Glimepiride—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000997	0.0023	CcSEcCtD
Glimepiride—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000995	0.0023	CcSEcCtD
Glimepiride—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000995	0.0023	CcSEcCtD
Glimepiride—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000991	0.00229	CcSEcCtD
Glimepiride—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000987	0.00228	CcSEcCtD
Glimepiride—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000985	0.00227	CcSEcCtD
Glimepiride—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000985	0.00227	CcSEcCtD
Glimepiride—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000984	0.00227	CcSEcCtD
Glimepiride—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000981	0.00226	CcSEcCtD
Glimepiride—Injury—Prednisone—chronic obstructive pulmonary disease	0.000975	0.00225	CcSEcCtD
Glimepiride—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000974	0.00225	CcSEcCtD
Glimepiride—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000972	0.00224	CcSEcCtD
Glimepiride—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00097	0.00224	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000966	0.00223	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000966	0.00223	CcSEcCtD
Glimepiride—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000965	0.00223	CcSEcCtD
Glimepiride—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000965	0.00223	CcSEcCtD
Glimepiride—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000965	0.00223	CcSEcCtD
Glimepiride—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00221	CcSEcCtD
Glimepiride—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000953	0.0022	CcSEcCtD
Glimepiride—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000949	0.00219	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000946	0.00218	CcSEcCtD
Glimepiride—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000945	0.00218	CcSEcCtD
Glimepiride—Glyburide—ALB—chronic obstructive pulmonary disease	0.000943	0.1	CrCbGaD
Glimepiride—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000942	0.00217	CcSEcCtD
Glimepiride—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000939	0.00217	CcSEcCtD
Glimepiride—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000935	0.00216	CcSEcCtD
Glimepiride—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00093	0.00215	CcSEcCtD
Glimepiride—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000927	0.00214	CcSEcCtD
Glimepiride—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000926	0.00214	CcSEcCtD
Glimepiride—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00213	CcSEcCtD
Glimepiride—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00213	CcSEcCtD
Glimepiride—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000921	0.00213	CcSEcCtD
Glimepiride—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000918	0.00212	CcSEcCtD
Glimepiride—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000917	0.00212	CcSEcCtD
Glimepiride—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000915	0.00211	CcSEcCtD
Glimepiride—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000915	0.00211	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000912	0.00211	CcSEcCtD
Glimepiride—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000911	0.0021	CcSEcCtD
Glimepiride—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000896	0.00207	CcSEcCtD
Glimepiride—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000889	0.00205	CcSEcCtD
Glimepiride—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000889	0.00205	CcSEcCtD
Glimepiride—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000884	0.00204	CcSEcCtD
Glimepiride—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000884	0.00204	CcSEcCtD
Glimepiride—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000881	0.00203	CcSEcCtD
Glimepiride—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000874	0.00202	CcSEcCtD
Glimepiride—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000873	0.00202	CcSEcCtD
Glimepiride—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000873	0.00202	CcSEcCtD
Glimepiride—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00201	CcSEcCtD
Glimepiride—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.00201	CcSEcCtD
Glimepiride—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000868	0.002	CcSEcCtD
Glimepiride—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000868	0.002	CcSEcCtD
Glimepiride—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000866	0.002	CcSEcCtD
Glimepiride—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00199	CcSEcCtD
Glimepiride—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000839	0.00194	CcSEcCtD
Glimepiride—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000835	0.00193	CcSEcCtD
Glimepiride—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000824	0.0019	CcSEcCtD
Glimepiride—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000824	0.0019	CcSEcCtD
Glimepiride—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000823	0.0019	CcSEcCtD
Glimepiride—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000822	0.0019	CcSEcCtD
Glimepiride—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000807	0.00186	CcSEcCtD
Glimepiride—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000803	0.00185	CcSEcCtD
Glimepiride—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000803	0.00185	CcSEcCtD
Glimepiride—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000792	0.00183	CcSEcCtD
Glimepiride—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000792	0.00183	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00079	0.00182	CcSEcCtD
Glimepiride—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000786	0.00182	CcSEcCtD
Glimepiride—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000779	0.0018	CcSEcCtD
Glimepiride—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.0018	CcSEcCtD
Glimepiride—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000775	0.00179	CcSEcCtD
Glimepiride—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000765	0.00177	CcSEcCtD
Glimepiride—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000765	0.00177	CcSEcCtD
Glimepiride—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000762	0.00176	CcSEcCtD
Glimepiride—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.00175	CcSEcCtD
Glimepiride—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000754	0.00174	CcSEcCtD
Glimepiride—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00075	0.00173	CcSEcCtD
Glimepiride—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000747	0.00173	CcSEcCtD
Glimepiride—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000742	0.00171	CcSEcCtD
Glimepiride—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00074	0.00171	CcSEcCtD
Glimepiride—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00074	0.00171	CcSEcCtD
Glimepiride—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000725	0.00167	CcSEcCtD
Glimepiride—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.00167	CcSEcCtD
Glimepiride—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000711	0.00164	CcSEcCtD
Glimepiride—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000711	0.00164	CcSEcCtD
Glimepiride—Rash—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00163	CcSEcCtD
Glimepiride—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00163	CcSEcCtD
Glimepiride—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00163	CcSEcCtD
Glimepiride—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00163	CcSEcCtD
Glimepiride—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000705	0.00163	CcSEcCtD
Glimepiride—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000701	0.00162	CcSEcCtD
Glimepiride—Headache—Formoterol—chronic obstructive pulmonary disease	0.000701	0.00162	CcSEcCtD
Glimepiride—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.0007	0.00162	CcSEcCtD
Glimepiride—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000699	0.00161	CcSEcCtD
Glimepiride—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000697	0.00161	CcSEcCtD
Glimepiride—Rash—Montelukast—chronic obstructive pulmonary disease	0.000691	0.0016	CcSEcCtD
Glimepiride—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00159	CcSEcCtD
Glimepiride—Headache—Montelukast—chronic obstructive pulmonary disease	0.000687	0.00158	CcSEcCtD
Glimepiride—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000678	0.00157	CcSEcCtD
Glimepiride—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00155	CcSEcCtD
Glimepiride—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00154	CcSEcCtD
Glimepiride—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00154	CcSEcCtD
Glimepiride—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000665	0.00153	CcSEcCtD
Glimepiride—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000665	0.00153	CcSEcCtD
Glimepiride—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000662	0.00153	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000653	0.00151	CcSEcCtD
Glimepiride—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000651	0.0015	CcSEcCtD
Glimepiride—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000643	0.00148	CcSEcCtD
Glimepiride—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000641	0.00148	CcSEcCtD
Glimepiride—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000631	0.00146	CcSEcCtD
Glimepiride—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00145	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000606	0.0014	CcSEcCtD
Glimepiride—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000596	0.00138	CcSEcCtD
Glimepiride—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000591	0.00137	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000586	0.00135	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—ADIPOQ—chronic obstructive pulmonary disease	0.000565	0.0723	CbGpPWpGaD
Glimepiride—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000554	0.00128	CcSEcCtD
Glimepiride—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000548	0.00127	CcSEcCtD
Glimepiride—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000544	0.00126	CcSEcCtD
Glimepiride—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000539	0.00125	CcSEcCtD
Glimepiride—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000539	0.00125	CcSEcCtD
Glimepiride—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000508	0.00117	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.00115	CcSEcCtD
Glimepiride—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000499	0.00115	CcSEcCtD
Glimepiride—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000496	0.00114	CcSEcCtD
Glimepiride—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000493	0.00114	CcSEcCtD
Glimepiride—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000481	0.00111	CcSEcCtD
Glimepiride—ABCC8—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.000477	0.061	CbGpPWpGaD
Glimepiride—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000474	0.00109	CcSEcCtD
Glimepiride—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000467	0.00108	CcSEcCtD
Glimepiride—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000466	0.00108	CcSEcCtD
Glimepiride—KCNJ11—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.000463	0.0592	CbGpPWpGaD
Glimepiride—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00106	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000446	0.00103	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00044	0.00102	CcSEcCtD
Glimepiride—Shock—Prednisone—chronic obstructive pulmonary disease	0.000433	0.001	CcSEcCtD
Glimepiride—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000992	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000983	CcSEcCtD
Glimepiride—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000969	CcSEcCtD
Glimepiride—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000401	0.000925	CcSEcCtD
Glimepiride—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000398	0.000919	CcSEcCtD
Glimepiride—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000395	0.000913	CcSEcCtD
Glimepiride—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000388	0.000895	CcSEcCtD
Glimepiride—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000383	0.000884	CcSEcCtD
Glimepiride—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.000882	CcSEcCtD
Glimepiride—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.000881	CcSEcCtD
Glimepiride—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00038	0.000876	CcSEcCtD
Glimepiride—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00038	0.000876	CcSEcCtD
Glimepiride—ABCC8—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000375	0.048	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000364	0.0465	CbGpPWpGaD
Glimepiride—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000838	CcSEcCtD
Glimepiride—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000831	CcSEcCtD
Glimepiride—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.000831	CcSEcCtD
Glimepiride—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000807	CcSEcCtD
Glimepiride—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000804	CcSEcCtD
Glimepiride—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00034	0.0435	CbGpPWpGaD
Glimepiride—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000749	CcSEcCtD
Glimepiride—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000729	CcSEcCtD
Glimepiride—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.000316	0.0404	CbGpPWpGaD
Glimepiride—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000312	0.000719	CcSEcCtD
Glimepiride—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00031	0.0396	CbGpPWpGaD
Glimepiride—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000301	0.000695	CcSEcCtD
Glimepiride—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000672	CcSEcCtD
Glimepiride—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000646	CcSEcCtD
Glimepiride—Rash—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000641	CcSEcCtD
Glimepiride—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000277	0.00064	CcSEcCtD
Glimepiride—Headache—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000637	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000269	0.0344	CbGpPWpGaD
Glimepiride—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000604	CcSEcCtD
Glimepiride—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.0316	CbGpPWpGaD
Glimepiride—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.0288	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000219	0.028	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00017	0.0217	CbGpPWpGaD
Glimepiride—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.0209	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000163	0.0208	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—TNF—chronic obstructive pulmonary disease	0.000162	0.0208	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000158	0.0202	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.0201	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000151	0.0193	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000137	0.0176	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000133	0.017	CbGpPWpGaD
Glimepiride—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.0152	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.0146	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000112	0.0143	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000109	0.0139	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.0137	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	7.86e-05	0.01	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.95e-05	0.00888	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.79e-05	0.00868	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.7e-05	0.00857	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APIP—chronic obstructive pulmonary disease	6.48e-05	0.00828	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APIP—chronic obstructive pulmonary disease	6.28e-05	0.00803	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.71e-05	0.0073	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.5e-05	0.00704	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.93e-05	0.00631	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.87e-05	0.00623	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.29e-05	0.00549	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GC—chronic obstructive pulmonary disease	4.17e-05	0.00534	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.16e-05	0.00532	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GC—chronic obstructive pulmonary disease	4.05e-05	0.00517	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.00511	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.88e-05	0.00496	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.76e-05	0.00481	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.52e-05	0.0045	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.48e-05	0.00445	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.33e-05	0.00425	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.92e-05	0.00374	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.88e-05	0.00369	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.47e-05	0.00316	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.44e-05	0.00312	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.41e-05	0.00308	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.28e-05	0.00291	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.25e-05	0.00288	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.24e-05	0.00287	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.21e-05	0.00283	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.21e-05	0.00283	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	2.19e-05	0.00279	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.12e-05	0.00272	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.1e-05	0.00268	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.00263	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2e-05	0.00255	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.00255	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.00242	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.00235	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.71e-05	0.00219	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-05	0.00202	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.00199	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.00196	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.00193	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.00186	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.0018	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.00176	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.00171	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.00156	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.13e-05	0.00145	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.00144	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.1e-05	0.00141	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.02e-05	0.00131	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	9.36e-06	0.0012	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	9.07e-06	0.00116	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	8.95e-06	0.00114	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	8.68e-06	0.00111	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.16e-06	0.00104	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.02e-06	0.000769	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.95e-06	0.00076	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.55e-06	0.000709	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.43e-06	0.000694	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5e-06	0.000639	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.17e-06	0.000533	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.11e-06	0.000526	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.83e-06	0.00049	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.63e-06	0.000465	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.47e-06	0.000316	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.36e-06	0.000302	CbGpPWpGaD
